Evidence map›Paper›PMID 36399813›Full record

ArticleGynecologic oncology2023

Persistent disparities of cervical cancer among American Indians/Alaska natives: Are we maximizing prevention tools?

A S Bruegl, J Emerson, K Tirumala

Open access · greenAbstract read
In one paragraph

Article in Gynecologic oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Understanding HPV Vaccine Uptake Among American Indian and Alaska Native College Students: A Scoping Review.International journal of environmental research and public health · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

A S BrueglDivision of Gynecologic Oncology, Department of OB/Gyn, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, United States of America. Electronic address: bruegl@ohsu.edu.
J EmersonDivision of Gynecologic Oncology, Department of OB/Gyn, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, United States of America.
K TirumalaNorthwest Portland Area Indian Health Board, Tribal Epidemiology Center, 2121 SW Broadway Street, Suite 300, Portland, OR 97201, United States of America.
Oregon Health & Science University · USNorthwest Portland Area Indian Health Board · US

Funding

Utilization of cervical cancer prevention tools and role of high-risk HPV type in the persistent cervical cancer disparities experienced by American Indian/Alaska Native womenK08CA245200 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI BRUEGL, AMANDA S · 2021 to 2025
$1.3M
NCI NIH HHS K08 CA245200NIMHD NIH HHS L60 MD015568
6 · The paper itself

Abstract

backgroundCervical cancer incidence and mortality disparities experienced by American Indian/Alaska Native (AI/AN) women have persisted for decades. Pap smear screening and HPV vaccination are powerful tools to prevent cervical cancer. We evaluated the utilization of these tools among AI/ANs living in the Pacific Northwest (PNW).

methodsThe Indian Health Service (IHS) National Data Warehouse's Epi Data Mart was analyzed using all healthcare visits from 2010 to 2020 from IHS, Tribal, and Urban Indian clinics in the PNW. Women ages 21-64 were included and considered up-to-date on pap smears if they had either cytology within 3 years or cytology with HPV testing within 5 years of the most recent clinical encounter. HPV vaccination rates for both sexes were calculated for individuals ages 9-26. HPV vaccination was considered complete if: two vaccines were received prior to age 15 or after three vaccinations if initiated after age 15.

findingsCervical cancer screening rates are below the national average of 73.5% ranging between 57.1% - 65.0%. Sub-analysis of age groups shows substantially lower rates of up-to-date pap smear screening in the 50-64 age group. HPV vaccination rates have increased over time for both sexes across all age groups. However, the current vaccination rate of 58.6% is well below the Healthy People 2030 goal of 84.3%.

interpretationCervical cancer screening and HPV vaccination are the cornerstones of cervical cancer prevention and early detection. These tools are underutilized and public health efforts can be strengthened to improve cervical cancer disparities in AI/AN women.

fundingAuthor ASB: Funding for this project has been provided through the Robert Wood Johnson Foundation Harold Amos Minority Faculty Development Grant and the National Cancer Institute K08 Mentored Clinical Scientist Development Award.

Indexed as

Alaska NativesIndians, North AmericanPapillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsAdolescentAdultAmerican Indian or Alaska NativeChildEarly Detection of CancerFemaleHumansMaleMiddle AgedYoung AdultPapillomavirus VaccinesAmerican Indians or Alaska NativesCervical cancer screeningHealth disparitiesHPVPapanicolaou testPappilomavirus vaccines

Identifiers

PMID36399813
PMCPMC9797436
OpenAlexW4309563569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.